ViRexx begins trading on American Stock Exchange

By E. Janene Geiss

Philadelphia, Dec. 23 - ViRexx Medical Corp. said it has received approval from the American Stock Exchange for the listing of its common shares on the Amex under the symbol "REX."

The stock began trading on Friday and closed at $1.18.

ViRexx's common shares will continue to trade on the Toronto Stock Exchange under the symbol "VIR."

"Achieving an Amex listing is part of a larger strategy to increase our exposure and presence in the United States as we increase our clinical activity. As we advance and develop our broad product pipeline, which includes the late-stage OvaRex MAb candidate that is in phase 3 trials, it is important that we continue to seek new ways to expand our accessible shareholder base. This listing supports ViRexx's product development by increasing our access to potential U.S. investors," Lorne Tyrrell, chief executive officer of ViRexx, said in the release.

ViRexx is a biotechnology company based in Edmonton, Alta., which develops therapeutic products for the treatment of cancer and chronic viral infections.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.